Long-term multicentre trial in chronic nonspecific lung disease: methodology and baseline assessment in adult patients. Dutch CNSLD Study Group

Airways obstruction and airways hyperresponsiveness are two dominant features in patients with chronic nonspecific lung disease (asthma and chronic obstructive pulmonary disease (COPD)). We set up a study to determine whether long-term (3 yrs) therapeutic intervention directed at airways obstruction and hyperresponsiveness is superior to one directed at airways obstruction alone. Patients were selected on functional criteria (age, baseline forced expiratory volume in one second (FEV1), and airways hyperresponsiveness) and, furthermore, extensively characterized by history, smoking habits, allergy, reversibility of airways obstruction and quality of life. The methodology and practical problems of setting up this large multicentre study are outlined, together with an analysis of baseline data. Standardization of methods and techniques and recruitment of patients required much effort, recruitment taking about twice as long as expected. A 3 month feasibility study allowed us to eliminate minor problems in the protocol. Over a 16 month period, 274 adult patients (18-60 yrs) from the out-patient clinics of six university centres entered the study; 99 met the diagnostic criteria for asthma, 51 for COPD, 88 for asthmatic bronchitis, and 36 could not be classified. Their mean (SD) FEV1% pred was 65.1 (15.2)%. Their geometric mean provoking concentration of histamine producing a 20% fall in FEV1 (PC20 histamine) was 0.28 mg.ml-1. In a multiple regression analysis, more severe airways hyperresponsiveness was associated with lower prechallenge FEV1% pred (p less than 0.0001), higher pack-years of smoking (p = 0.0099), blood eosinophil count (p = 0.0004), skin test reactivity (p = 0.0047) and with female sex (p = 0.0302). We conclude that setting up long-term multicentre trials in chronic nonspecific lung disease (CNSLD) is feasible and that these may offer valuable information on treatment and outcome of the disease.

This article has been cited by other articles:

				D L Hahn, P S Burge, and S A Lewis Ethics of placebo controlled studies of inhaled steroids for COPD * Authors' reply Thorax, June 1, 2004; 59(6): 539 - 540. [Full Text] [PDF]

				D. L. Hahn Chlamydia pneumoniae and the "Dutch Hypothesis" Chest, November 1, 2002; 122(5): 1510 - 1512. [Full Text] [PDF]

				W. R. Douma, H. A. M. Kerstjens, A. de Gooijer, S. E. Overbeek, G. H. Koeter, and D. S. Postma Initial Improvements in Lung Function and Bronchial Hyperresponsiveness Are Maintained During 5 Years of Treatment With Inhaled Beclomethasone Dipropionate and Terbutaline Chest, January 1, 2002; 121(1): 151 - 157. [Abstract] [Full Text] [PDF]

				L.-P. Ho, F. T. Wood, A. Robson, J. A. Innes, and A. P. Greening Atopy Influences Exhaled Nitric Oxide Levels in Adult Asthmatics Chest, November 1, 2000; 118(5): 1327 - 1331. [Abstract] [Full Text] [PDF]

				R. E. T. NOCKER, F. R. WELLER, T. A. OUT, M. J. de RIEMER, H. M. JANSEN, and J. S. van der ZEE A Double-blind Study on the Effect of Inhaled Corticosteroids on Plasma Protein Exudation in Asthma Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1499 - 1505. [Abstract] [Full Text] [PDF]

				M. O. TURNER, D. TAYLOR, R. BENNETT, and J. MARK FITZGERALD A Randomized Trial Comparing Peak Expiratory Flow and Symptom Self-management Plans for Patients with Asthma Attending a Primary Care Clinic Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 540 - 546. [Abstract] [Full Text]